SEI Investments
DNTH icon

SEI Investments’s Dianthus Therapeutics DNTH Stock Holding History

SEI Investments’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.99M Buy
92,280
+51
+0.1% +$4.45K 0.01% 1180
2026
Q1 		$7.74M Buy
92,229
+78,388
+566% +$4.54M 0.01% 1269
2025
Q4 		$570K Sell
13,841
-434
-3% -$16.8K ﹤0.01% 2450
2025
Q3 		$562K Buy
+14,275
New +$365K ﹤0.01% 2178

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

SEI Investments's DNTH Position: Q2 2026 in Review

SEI Investments increased its Dianthus Therapeutics (DNTH) stake by 0.06% in Q2 2026, buying an estimated $4.45K and bringing the position to 92,280 shares worth $8.99M. The position accounts for 0.01% of the portfolio, ranked #1180.

SEI Investments first reported a position in DNTH in Q3 2025 and has held it in 4 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • SEI Investments held 92,280 shares of Dianthus Therapeutics worth $8.99M as of Q2 2026.
  • SEI Investments bought 51 Dianthus Therapeutics shares in Q2 2026, an estimated $4.45K.
  • Dianthus Therapeutics made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1180 holding.
  • SEI Investments first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.